|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.87/0.89
|
企業價值
3.98B
|
資產負債 |
每股賬面淨值
-1.37
|
現金流量 |
現金流量率
--
|
損益表 |
收益
489.68M
|
每股收益
0.21
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to treatments for various diseases. |